BMRN

BioMarin Pharmaceutical Inc. News Headlines

$75.01
*  
0.69
0.93%
Get BMRN Alerts
*Delayed - data as of Oct. 23, 2014  -  Find a broker to begin trading BMRN now
Exchange: NASDAQ
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By
BioMarin to Raise Funds - Analyst Blog
10/8/2013 11:40:01 AM - Zacks.com


Cramer's Lightning Round - United Therapeutics Is A Winner (10/2/13)
10/3/2013 5:57:00 AM - Seeking Alpha


Insiders Are Selling BioMarin Pharmaceutical
9/30/2013 3:34:00 PM - Seeking Alpha


Encouraging Pipeline Data from BioMarin - Analyst Blog
9/30/2013 11:40:01 AM - Zacks.com


Pipeline Progress at BioMarin - Analyst Blog
9/24/2013 11:17:58 AM - Zacks.com


Market Primer: Friday, September 20: US Markets Fall As Investors Re-Evaluate
9/20/2013 6:45:44 AM - Benzinga


Sector Update: Healthcare Flat to Higher Pre-Market; ISIS up 4%
9/19/2013 8:44:48 AM - MT Newswires


Sector Update: Healthcare
9/19/2013 8:43:59 AM - MT Newswires


Pre-Market Most Active for Sep 19, 2013 : RAD, NOK, ORCL, BMRN, P, SNY, ONXX, A, FSC, CSCO, FB, DRYS
9/19/2013 8:39:54 AM - NASDAQ.com News


Pipeline Update from BioMarin - Analyst Blog
9/18/2013 11:40:01 AM - Zacks.com


Cramer's Mad Money - The Raging Bulls Of Biotech (9/17/13)
9/18/2013 5:54:00 AM - Seeking Alpha


Healthcare Stocks Mixed Near Bell; BioMarin Pharma Climbing With Morquio A Treatment Set by FDA Advisory Review
9/17/2013 3:57:56 PM - MT Newswires


Sector Update: Healthcare
9/17/2013 3:57:11 PM - MT Newswires


Niraparib And Rolapitant Will Take Tesaro To New Heights
9/13/2013 3:21:00 PM - Seeking Alpha


Catalyst Pharma Raises Funds - Analyst Blog
9/11/2013 5:57:24 PM - Zacks.com


Are Biotech M&A Premiums Already Built In? Valuations Do Matter
9/3/2013 1:54:00 PM - Seeking Alpha


FDA Designation for CPRX's Firdapse - Analyst Blog
8/28/2013 6:25:01 PM - Zacks.com


Cramer's Mad Money - Who's Next In Biotech (8/27/13)
8/28/2013 6:16:00 AM - Seeking Alpha


What Does The FDA's Breakthrough Designation Mean For Investors?
8/26/2013 12:45:00 PM - Seeking Alpha


Is There Any Substance To The Buyout Rumors Surrounding BioMarin And Catalyst?
8/26/2013 4:19:00 AM - Seeking Alpha


Catalyst Pharmaceutical Partners: A Compelling Pipeline For Long-Term Growth
8/19/2013 12:16:00 PM - Seeking Alpha


Narrower-Than-Expected Loss at BioMarin - Analyst Blog
7/26/2013 4:45:01 PM - Zacks.com


After-Hours Earnings Report for July 25, 2013 : AMZN, GILD, SBUX, MCK, CB, CERN, NEM, RSG, PFG, KLAC, BMRN, CBG
7/25/2013 2:00:06 PM - NASDAQ.com News


BioMarin Stays Neutral - Analyst Blog
7/8/2013 5:55:01 PM - Zacks.com


BioMarin Files Vimizim MA in Brazil - Analyst Blog
7/5/2013 4:20:01 PM - Zacks.com